J. Vane, Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs, Nature New Biology, vol.231, issue.25, pp.232-235, 1971.
DOI : 10.1038/newbio231232a0

M. Burian and G. Geisslinger, COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites, Pharmacology & Therapeutics, vol.107, issue.2, pp.139-154, 2005.
DOI : 10.1016/j.pharmthera.2005.02.004

S. Ito, E. Okuda-ashitaka, and T. Minami, Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin, Neuroscience Research, vol.41, issue.4, pp.299-332, 2001.
DOI : 10.1016/S0168-0102(01)00289-9

D. Simmons, R. Botting, and T. Hla, Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition, Pharmacological Reviews, vol.56, issue.3, pp.387-437, 2004.
DOI : 10.1124/pr.56.3.3

D. Stichtenoth and J. Frolich, The Second Generation of COX-2 Inhibitors, Drugs, vol.96, issue.1, pp.33-45, 2003.
DOI : 10.2165/00003495-200363010-00003

T. Warner and J. Mitchell, Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic, The FASEB Journal, vol.18, issue.7, pp.790-804, 2004.
DOI : 10.1096/fj.03-0645rev

S. Solomon, J. Mcmurray, M. Pfeffer, J. Wittes, R. Fowler et al., The Adenoma Prevention with Celecoxib (APC) Study

. Investigators, Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention, N Engl J Med, vol.352, pp.1071-1080, 2005.